Center for Infection and Immunity of Lille
Created in 2010
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
2,337Activities
Entity types
Location
1 Rue du Professeur Calmette, 59000 Lille, France
Lille
France
Employees
Scale: 51-200
Estimated: 43
Engaged corporates
3
0 1Added in Motherbase
7 months ago
deeptech Value proposition
Infectious diseases are today still leading causes of global mortality and morbidity. One death out of four is due to infections, a proportion just behind cardiovascular diseases and twice as high as mortality due to cancer. This proportion is even higher in children, where infectious diseases are the first cause of death. In addition, the prevalence of chronic inflammatory and auto-immune diseases are on the rise, especially in the industrialized world. Therefore, the Center for Infection and Immunity of Lille is devoted to studying some of the most prevalent infectious disease, such as tuberculosis, malaria, hepatitis C, influenza, schistosomiasis, toxoplasmosis, pertussis, pneumococcal pneumonia, but also continuous threads, such as plague and several parasitic and viral diseases. These infections cannot be studied independently of their host environment, especially the immune system. Therefore, the second major area of research concerns the immune reaction against infections, and related immune dysfunctions of non-infectious diseases, such as allergic asthma and chronic obstructive pulmonary disease, which may be a leading cause of death by 2050. The objectives of the center are to gain deeper knowledge on the molecular and cellular mechanisms of these diseases and to apply this knowledge to the development of improved diagnostics, vaccines and therapeutics.
research, immunity, inflammation, infectious diseases, bacteria, viruses, parasites, antibiotic resistance, respiratory, vaccines, preclinical studies, and clinical trialsOriginal language
Infectious diseases are today still leading causes of global mortality and morbidity. One death out of four is due to infections, a proportion just behind cardiovascular diseases and twice as high as mortality due to cancer. This proportion is even higher in children, where infectious diseases are the first cause of death. In addition, the prevalence of chronic inflammatory and auto-immune diseases are on the rise, especially in the industrialized world. Therefore, the Center for Infection and Immunity of Lille is devoted to studying some of the most prevalent infectious disease, such as tuberculosis, malaria, hepatitis C, influenza, schistosomiasis, toxoplasmosis, pertussis, pneumococcal pneumonia, but also continuous threads, such as plague and several parasitic and viral diseases. These infections cannot be studied independently of their host environment, especially the immune system. Therefore, the second major area of research concerns the immune reaction against infections, and related immune dysfunctions of non-infectious diseases, such as allergic asthma and chronic obstructive pulmonary disease, which may be a leading cause of death by 2050. The objectives of the center are to gain deeper knowledge on the molecular and cellular mechanisms of these diseases and to apply this knowledge to the development of improved diagnostics, vaccines and therapeutics.
Home -
Default Description
https://www.ciil.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Région Hauts-de-France National and local authorities, Government Administration | Région Hauts-de-France National and local authorities, Government Administration | Other 3 Jun 2024 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 29 Feb 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 24 Aug 2024 | | |